MARKET

BMKDF

BMKDF

Biomark Diagnostics Inc
OTCMQB
0.424
+0.025
+6.30%
Closed 10:48 06/09 EDT
OPEN
0.399
PREV CLOSE
0.399
HIGH
0.424
LOW
0.399
VOLUME
4.20K
TURNOVER
1.68K
52 WEEK HIGH
0.450
52 WEEK LOW
0.203
MARKET CAP
45.16M
P/E (TTM)
-34.7664
1D
5D
1M
3M
1Y
5Y
1D
BioMark Diagnostics secures USPTO patent approval for urine-based lung cancer test
Seeking Alpha · 14h ago
BioMark wins US patent allowance for urine-based lung cancer screening method
PUBT · 14h ago
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
Newsfile · 14h ago
Weekly Report: what happened at BMKDF last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at BMKDF last week (0525-0529)?
Weekly Report · 06/01 09:10
Weekly Report: what happened at BMKDF last week (0518-0522)?
Weekly Report · 05/25 09:11
Weekly Report: what happened at BMKDF last week (0511-0515)?
Weekly Report · 05/18 09:11
Weekly Report: what happened at BMKDF last week (0504-0508)?
Weekly Report · 05/11 09:10
More
About BMKDF
BioMark Diagnostics Inc. is a developer of liquid biopsy tests for the early detection of cancer that leverages the power of metabolomics and machine learning algorithms. The Company's proprietary technology utilizes a simple blood draw to detect the presence of cancer-associated biomarkers, enabling earlier diagnosis and improved patient outcomes. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. It is also engaged in developing accessible diagnostic solutions to address unmet medical needs in oncology. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a liquid biopsy metabolic panel assay, which is instrumental for early-stage diagnosis of lung cancer.

Webull offers BioMark Diagnostics Inc stock information, including OTCMQB: BMKDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMKDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMKDF stock methods without spending real money on the virtual paper trading platform.